EP2088870A2 - Verfahren zur herstellung von theaflavinen - Google Patents

Verfahren zur herstellung von theaflavinen

Info

Publication number
EP2088870A2
EP2088870A2 EP07822618A EP07822618A EP2088870A2 EP 2088870 A2 EP2088870 A2 EP 2088870A2 EP 07822618 A EP07822618 A EP 07822618A EP 07822618 A EP07822618 A EP 07822618A EP 2088870 A2 EP2088870 A2 EP 2088870A2
Authority
EP
European Patent Office
Prior art keywords
theaflavins
catechins
leaf
reaction mixture
tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07822618A
Other languages
English (en)
French (fr)
Inventor
George Robert Hodges
Jacek Paul Obuchowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Unilever NV
Original Assignee
Unilever PLC
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC, Unilever NV filed Critical Unilever PLC
Priority to EP07822618A priority Critical patent/EP2088870A2/de
Publication of EP2088870A2 publication Critical patent/EP2088870A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/08Oxidation; Fermentation
    • A23F3/10Fermentation with addition of microorganisms or enzymes

Definitions

  • the present invention relates to the production of theaflavins .
  • the present invention relates to an improved process for the production of theaflavins from catechins and to the enrichment of catechin-containing material (such as tea) with theaflavins.
  • catechin-containing material such as tea
  • the present invention also relates to leaf tea products enriched with theaflavins.
  • Green tea leaf contains colourless polyphenols known as catechins.
  • catechins During oxidative fermentation of green leaf to produce black tea the catechins undergo oxidative biotransformations, through their quinones, into dimeric compounds known as theaflavins (TFs) and higher molecular weight compounds known as thearubigins (TRs) .
  • TFs and TRs are responsible for the orange and brown colours of black tea infusions and products as well as making significant contributions to the astringency and body of the made tea. TRs are larger in size and darker in colour than TFs.
  • TFs As well as affecting tea colour, TFs have been recognised as providing the "brightness” and “briskness” quality attributes of tea. In fact, TF content is known to correlate with the quality of black tea. Moreover, TFs have been shown to have several positive health benefits. Some of these benefits may be directly linked to the antioxidant properties of TFs. The purported benefits include lowering blood lipid levels (e.g. cholesterol), anti-inflammation effects and anti-tumour effects. Thus there is a need to provide products (especially tea products) with enhanced levels of TFs, as well as a need to provide more efficient processes for synthesising TFs.
  • blood lipid levels e.g. cholesterol
  • anti-inflammation effects e.g. anti-tumour effects
  • optimisation of TF production during tea manufacture is not simply a matter of the control of a single chemical reaction.
  • the oxidative polymerisations occurring during TF and TR formation are highly complex and include biochemical oxidations mediated by polyphenol oxidase and/or peroxidase enzymes present in the leaf as well as direct chemical combinations of reactive species.
  • the polymerisations are complex even when performed in vitro and in the absence of complex tea chemicals. To illustrate this complexity consider that, whilst TF formation requires the dimerisation of catechins (through their quinones) , catechins also initiate the destruction of TFs by conversion to TRs (also through the catechin quinones) .
  • TF level increases to a maximum and then decreases again.
  • the fermentation is typically stopped when the TF level hits this maximum value but this is wasteful since the system still contains active reagents which could be converted to TFs and, worse still, these active reagents have been shown to slowly degrade the TFs during storage in the subsequent month after manufacture (see J. B. Cloughley, J. Sci. Food Agric, 1981, 32,
  • the process is reported to result in an increase in TFs in the dhool of the mixture which is larger than would be predicted by a purely additive relationship between the TF level of the first and second supplies.
  • the macerated dhool preferably comprises between 10 and 50% of the mixture on a dry weight basis, which would lead to the mixture comprising a relatively high level of catechins, compared with that of the macerated dhool .
  • the present invention is based, in part, on the realisation that the different reaction rates and pathways occurring during fermentation can be manipulated in order to increase the maximum level of TFs attainable during fermentation and/or allow for stabilisation of the TF level attained.
  • forming a reaction mixture having a specific ratio (R) of catechins to theaflavins during fermentation leads to a high yield of theaflavins and/or increased stability of theaflavins produced by the fermentation.
  • the present invention provides a process for producing a product enriched in theaflavins, the process comprising the steps of: (a) providing a first material comprising theaflavins and a second material comprising catechins;
  • the invention provides a leaf tea product comprising theaflavins in an amount of greater than 72 mg per g of dry leaf.
  • the leaf tea product of the second aspect is preferably obtained and/or obtainable using the process of the first aspect.
  • Figure 1 is a cross-sectional elevation of a reactor for use in an embodiment of the process of the invention.
  • tea refers to material from Camellia sinensis var. sinensis and/or Camellia sinensis var. assamica.
  • Tea leaf refers to tea leaves and/or stem in an uninfused form. Tea which has undergone a fermentation step is known as “black tea”, whereas unfermented tea is known as “green tea”. Partially fermented tea is known as “oolong tea”.
  • tea product refers to tea leaf which has been dried to a moisture content of less than 30% by weight, more preferably to a moisture content of from 1 to 10% by weight.
  • Tea extract refers to solids that have been extracted with a solvent from tea leaf and which are soluble in boiling water.
  • the term "theaflavins" is used as a generic term for theaflavin, isotheaflavin, neotheaflavin, theaflavin-3- gallate, theaflavin-3' -gallate, theaflavin-3, 3' -digallate, epitheaflavic acid, epitheaflavic acid-3' -gallate, theaflavic acid, theaflavic acid-3' -gallate and mixtures thereof.
  • the structures of these compounds are well-known (see, for example, structures xi-xx in Chapter 17 of "Tea - Cultivation to consumption", K. C. Willson and M.N.
  • the term theaflavins includes salt forms of these compounds .
  • the preferred theaflavins are theaflavin, theaflavin-3-gallate, theaflavin-3' -gallate, theaflavin-3, 3' -digallate and mixtures thereof, as these theaflavins are most abundant in natural sources, such as black tea.
  • the term "mono-gallated theaflavins" is used as a generic term for theaflavin-3-gallate, theaflavin-3' -gallate and mixtures thereof.
  • the most preferred theaflavin is theaflavin-3-gallate as this theaflavin has been found to be most effective at reducing blood lipid levels.
  • catechins is used as a generic term for catechin, gallocatechin, catechin gallate, gallocatechin gallate, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, and mixtures thereof.
  • shallow catechins is used as a generic term for catechin, catechin gallate, epicatechin, epicatechin gallate and mixtures thereof.
  • gallo-catechins is used as a generic term for gallocatechin, gallocatechin gallate, epigallocatechin, epigallocatechin gallate, and mixtures thereof.
  • FERMENTATION refers to the oxidative transformation of catechins into theaflavins and, optionally, into thearubigins .
  • Reversed-phase high performance liquid chromatography is used to quantify the amount of theaflavins and catechins resulting from exhaustive extraction of a portion of a reaction mixture or leaf tea product as follows: Sample Preparation
  • reaction mixture or leaf tea product is mixed with 3 parts by weight of 70% (v/v) aqueous methanol and held at 7O 0 C for 10 minutes. 2. The liquid extract is then removed from any solid residue by filtering through muslin.
  • Solvents A: 2% acetic acid in acetonitrile
  • Isocratic Quantification Peak area relative to a calibration curve constructed daily. Calibration curve is constructed from caffeine and the concentration of catechins is calculated using the relative response factors of the individual catechins to caffeine (from the ISO catechin method - ISO/CD 14502-2) . Individual caffeine standards (Sigma, Poole, Dorset, UK) are used as peak identification markers.
  • Solvents A: 2% acetic acid in acetonitrile
  • the catechins are eluted at the beginning of the chromatogram in a broad unresolved peak and the theaflavins are eluted between 5-15 min. Detection is at 274 nm. Peak area is measured relative to a calibration curve constructed daily. The calibration curve is constructed from a series of solutions containing known amounts of a tea extract previously analysed against pure theaflavin standards.
  • CSTR Continuous Stirred-Tank Reactor
  • the stirring means should be such as to ensure proper mixing. Simply dividing the volume of the tank by the average volumetric flow rate through the tank gives the residence time (the average amount of time a discrete quantity of reagent spends inside the tank) . At steady-state, the mass flow rate into the tank equals the mass flow rate out.
  • the process of the present invention comprises the steps of:
  • R is less than 3, more preferably less than 2.5 and most preferably less than 2. However, we also believe that too low a proportion of catechins should be avoided as this may lead to a low rate of formation of the theaflavins and thus it is preferred that R is greater than 0.15, more preferably greater than 0.3 and most preferably at least 0.7. Formation of the preferred theaflavins (theaflavin, theaflavin-3- gallate, theaflavin-3' -gallate, theaflavin-3, 3' -digallate and mixtures thereof) requires the quinone from both a simple and a gallo-catechin to meet and react.
  • the catechins of the reaction mixture in step (b) comprise at least one simple catechin and at least one gallo-catechin. More preferably, the catechins of the reaction mixture in step (b) are a mixture of catechin, gallocatechin, catechin gallate, gallocatechin gallate, epicatechin, epigallocatechin, epicatechin gallate and epigallocatechin gallate.
  • the relative amount of the simple catechins and gallo-catechins has an influence on the rate of destruction and formation of theaflavins.
  • the quinone of a simple catechin can initiate the destruction of TFs and gallo-catechins can inhibit this destruction by removing the simple catechin quinone.
  • the first and second materials are preferably contacted in step (b) such that the catechins of the reaction mixture comprises at least 10% gallo-catechins by weight of the catechins, more preferably at least 20% and most preferably at least 30%.
  • the first and second materials are contacted in step (b) such that the catechins of the reaction mixture comprises less than 70% gallo-catechins by weight of the catechins, more preferably less than 60% and most preferably less than 50%.
  • the most preferred gallo-catechin is epigallocatechin gallate.
  • the process may be used for synthesising theaflavins from substantially pure catechins, but is preferably used to enrich the theaflavin content of tea leaf.
  • at least one of the first and second materials is macerated tea leaf.
  • certain endogenous enzymes in the tea leaf catalyse oxidation of catechins to theaflavins and so it is also preferred that at least one of the first and second materials is tea leaf which has not been heat-treated such as to deactivate these endogenous enzymes.
  • the tea leaf has not been heated to a temperature of greater than 7O 0 C, more preferably not greater than 6O 0 C and most preferably not greater than 5O 0 C.
  • the first material is tea leaf, it is preferably at least partially fermented tea leaf.
  • the second material is tea leaf, it is preferably substantially unfermented tea leaf.
  • the first and/or second material may optionally be withered tea leaf.
  • tea extracts especially aqueous tea extracts.
  • first material and/or second material may be tea extract. If the first material is tea extract, it is preferably at least partially fermented tea extract. If the second material is tea extract, it is preferably substantially unfermented tea extract.
  • first and/or second material may each comprise a plurality of substances.
  • the first material may, for example, comprise at least two substances selected from at least partially fermented tea leaf, at least partially fermented tea extract and purified theaflavins.
  • the second material may, for example, comprise at least two substances selected from substantially unfermented tea leaf, substantially unfermented tea extract, purified catechins, purified gallo-catechins and purified simple catechins. Where a material comprises a plurality of substances, these substances may be combined prior to, or simultaneous with, step (b) .
  • the first material preferably comprises theaflavins in an amount of from 0.01 to 50% by dry weight of the first material, more preferably from 0.1 to 10% and most preferably from 0.5 to 5%.
  • the first material also preferably comprises catechins .
  • the first material may suitably be provided by at least partially fermenting a portion of the second material.
  • the second material preferably comprises catechins in an amount of from 7 to 100% by dry weight of the second material, more preferably of from 9 to 50% and most preferably from 10 to 20%.
  • the catechins of the second material preferably comprise at least one simple catechin and at least one gallo-catechin.
  • the catechins of the second material preferably comprise gallo- catechins in an amount of at least 10% by weight of the catechins, more preferably at least 20% and most preferably at least 30%.
  • the first and second materials may be contacted in any suitable manner to provide the reaction mixture with the desired ratio R.
  • the materials are contacted in a liquid medium, most preferably an aqueous medium.
  • the aqueous medium is water substantially free of buffer salts, as these salts are found unnecessary and complicate recovery of the theaflavins from the reaction mixture.
  • the reaction mixture preferably comprises at least one oxidative enzyme.
  • oxidative enzyme is meant an enzyme for catalysing the oxidatitve biotransformation of catechins into theaflavins.
  • the at least one oxidative enzyme may be added to the reaction mixture in substantially purified form. Suitable enzymes include polyphenoloxidase and/or peroxidise. Alternatively or additionally, the enzyme may be present as part of tea leaf, especially where the first and/or second material comprises tea leaf.
  • the at least one oxidative enzyme may alternatively or additionally be present as part of a washed tea leaf preparation. Washed tea leaf preparations comprise tea leaf from which the majority of the water-extractable solids have been removed and act as an immobilised enzyme source.
  • Suitable washed leaf preparations are described, for example, in S. Bonnely et al . , "A model oxidation system to study oxidised phenolic compounds present in black tea", Food Chemistry, 2003, a3, pp.485-495.
  • the two materials are preferably contacted whilst applying mechanical agitation, for example by co-extrusion through an extruder such as a rotorvane.
  • the first material and the second material are contacted in step (b) in a weight ratio of from 1.01:1 to 100:1, more preferably from 1.5:1 to 50:1, and most preferably from 3:1 to 10:1 on a dry weight basis.
  • the fermentation step (c) may comprise any suitable fermentation, including solid-state fermentation, liquid state fermentation and/or slurry fermentation. Where at least one of the materials is tea leaf, slurry fermentation is particularly effective. Suitable slurry fermentation processes are disclosed, for example, in US 3,649,297 (Tenco Brooke Bond Ltd) or US 3,812,266 (Thomas J. Lipton Inc.) .
  • the preferred fermentation temperature is from 10 to 4O 0 C, more preferably from 15 to 25 0 C. Too low a temperature results in a slow rate of fermentation whilst too high a temperature may result in deactivation of oxidative enzymes and/or generation of unwanted reaction products.
  • the reaction mixture is preferably aerated during fermentation. Preferably the aeration is such as to produce an oxygen concentration in the reaction mixture of at least 25% of the concentration of oxygen in air-saturated water at 2O 0 C, more preferably at least 50% and most preferably from 70 to 100%.
  • the duration of the fermentation is preferably at least 5 minutes, more preferably at least 30 minutes and most preferably at least 1 hour.
  • the duration is also preferably less than 24 hours, more preferably less than 10 hours, most preferably less than 5 hours .
  • the process comprises the additional step of contacting at least one further portion of the second material with the reaction mixture to maintain the weight ratio of catechins to theaflavins in the range R during at least part of the fermentation step (c) . More preferably a plurality of further portions of the second material are contacted with the reaction mixture in order to maintain the weight ratio of catechins to theaflavins in the range R for at least 20% of the duration of the fermentation step (c) , more preferably at least 30% and optimally from 50 to 90% of the duration.
  • the step of contacting at least one further portion of the second material with the reaction mixture may additionally or alternatively be to maintain the amount of gallo-catechins in the reaction mixture in the range of 10% to 70% by weight of the catechins, more preferably from 20% to 60% and most preferably from 30% to 50%.
  • R is maintained at a steady state in the reaction mixture for at least 20% of the duration of the fermentation, more preferably at least 30% and optimally from 50 to 90% of the duration.
  • the steady state is suitable achieved by means of a continuous stirred tank reactor.
  • Recovery of the product in step (d) preferably comprises the step of arresting the fermentation.
  • Arresting fermentation preferably involves heating the reaction mixture to deactivate any oxidative enzymes in the reaction mixture and/or drying the reaction mixture to a water content of less than 30%, more preferably to a moisture content of from 1 to 10% by weight.
  • the enzyme deactivation and drying may be achieved simultaneously by firing the reaction mixture, as in conventional tea manufacture.
  • Alternative means may be used for deactivating the enzymes, such as addition of an organic solvent to the reaction mixture.
  • Recovery of the product from the reaction mixture may, for example, comprise at least one unit operation selected from solvent extraction, electrodialysis, membrane separation and chromatography.
  • Solvent extraction may comprise extracting the reaction mixture with a solvent in which theaflavins are highly soluble.
  • the solvent will usually be an organic solvent.
  • Chromatography comprises contacting the theaflavins in the reaction mixture with a chromatographic medium, such as an adsorbant material.
  • a chromatographic medium such as an adsorbant material.
  • the reaction mixture is extracted as described above.
  • the product may be recovered as a single fraction or as multiple fractions.
  • the product may be recovered in multiple fractions, each fraction being enriched in an individual theaflavin.
  • Use of a chromatographic medium is particularly suitable for recovering the product in such multiple fractions.
  • the process of the invention has been found to be capable of producing leaf tea products with very high levels of theaflavins.
  • the leaf tea product comprises theaflavins in an amount of greater than 72 mg per g of dry leaf, preferably at least 75 mg per g of dry leaf, most preferably from 80 to 150 mg per g of dry leaf.
  • the leaf tea product produced by the process may additionally comprise catechins .
  • the weight ratio of catechins to theaflavins is preferably in the range of R as described hereinabove.
  • the theaflavins of the leaf tea product preferably comprise at least 90% of a mixture of theaflavin, theaflavin-3-gallate, theaflavin-3' -gallate and theaflavin-3, 3' -digallate by weight of the theaflavins, more preferably from 95 to 100%.
  • the theaflavins comprise at least 25% theaflavin-3-gallate by weight of the theaflavins, more preferably at least 30% and most preferably from 35 to 50%.
  • the leaf tea product is preferably packaged in an infusion package such as a tea bag.
  • the leaf tea product may be used to prepare a beverage, for example by infusing the product in an aqueous medium.
  • the leaf was withered in trays at an air temprtaure of 2O 0 C for 18 hours (moisture reduced to 70.8% by weight), before being macerated using a vegetable cutter (AlexanderwerkTM AWBS 150) and three passes through a CTC machine (rotor speed ratio 10:1). The fresh macerated leaf was then rapidly frozen in a blast freezer.
  • the time from first cut of the leaf to freezing was kept to a minimum and was always less than 15 minutes.
  • the reactor comprised a cylindrical tank (1) having a radius of 13 cm and a height of 22 cm. Air was pumped into the bottom of the reactor through an inlet tube (3a) of a ring sparger (3) of radius 4.5 cm.
  • the ring sparger had 11 holes (3b) on top and 2 on the bottom.
  • the ring sparger (3) was arranged concentrically with the tank (1) as it was found that in order to achieve good gas mass transfer, contact of gas bubbles with the sides of the vessel should be avoided.
  • a downward-pumping turbine agitator Directly above the sparger was positioned a downward-pumping turbine agitator
  • a port (5) in the top of the reactor (1) allowed for addition of reactants and/or removal of product.
  • the whole reactor was placed in a water bath to control the temperature at 20-25 0 C.
  • the oxygen concentration was 60-100% of the air- saturated concentration.
  • a control batch fermentation was performed as follows. Frozen leaf (175 g) was added in one aliquot to 750 mL water whilst sparging and agitating the mixture. Fermentation was then continued for 180 minutes with regular sampling of the reaction mixture to determine the content of theaflavins.
  • Fermentation of a reaction mixture having a major proportion of fresh leaf and a minor portion of fermented leaf was investigated as follows. Frozen leaf (61.25 g) was added to 750 ml water and allowed to ferment for 30 minutes with agitation and sparging. This fermented slurry was then combined with 113.75 g more frozen leaf. Fermentation was then continued for 180 minutes with regular sampling of the reaction mixture to determine the content of theaflavins.
  • Ro is the weight ratio of catechins to theaflavins in the reaction mixture directly after addition of the last aliquot of frozen leaf.
  • RQ is the steady state value of R.
  • C max is the maximum amount of theaflavins in the reaction mixture .
  • t max is the time after addition of the last aliquot of leaf when C max was achieved.
  • C f is the amount of theaflavins in the reaction mixture at the end of the experiment (180 minutes after addition of the last aliquot of frozen leaf) .
  • fermenting a reaction mixture wherein the amount of theaflavins is relatively high compared with the amount of catechins not only allows for a relatively high yield of theaflavins (high QQ X ) , but allows for increased stability of the theaflavins in the reaction mixture (high C f ) .
  • This Example compares a batch fermentation with a process according to the invention wherein the first material is formed by fermenting tea leaf with additional purified catechin.
  • the process of Experiment 6 also resulted in a relatively high yield of the valuable mono-gallated thealflavins .
  • the reaction mixture of Experiment 6 comprised 22 mg theaflavin-3-gallate and 13 mg theaflavin-3' - gallate per g of dry leaf, compared with 12 mg and 7 mg respectively per g of dry leaf for the reaction mixture of Experiment 7.
  • the process of Experiment 8 also resulted in a relatively high yield of the valuable mono-gallated thealflavins, although in this case, the amount of theaflavin-3-gallate was less than that of theaflavin-3' -gallate.
  • the reaction mixture of Experiment 8 comprised 16 mg theaflavin-3-gallate and 18 mg theaflavin-3' -gallate per g of dry leaf.
  • Comparison of the results of Experiments 6 and 8 demonstrates the influence of the relative amounts of simple catechins to gallo- catechins in the reaction mixture on the yield of theaflavins.
  • purified epicatechin was added which necessarily decreased the proportion of gallo-catechins in the reaction mixture compared with Experiment 8.
  • the total yield of theaflavins was lower for Experiment 6 than Experiment 8.
  • An even larger effect is observed in batch fermentation, as is apparent from a comparison of the yields in Experiments 4 (no added simple catechin) and 7 (added simple catechin) .
  • This Example demonstrates the manufacture of a leaf tea product having a high level of theaflavin-3-gallate.
  • the leaf tea had a total theaflavin content of 79 mg and a theaflavin-3-gallate content of 30 mg per g of dry leaf.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tea And Coffee (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP07822618A 2006-12-01 2007-11-15 Verfahren zur herstellung von theaflavinen Withdrawn EP2088870A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07822618A EP2088870A2 (de) 2006-12-01 2007-11-15 Verfahren zur herstellung von theaflavinen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06125217 2006-12-01
PCT/EP2007/062374 WO2008065007A2 (en) 2006-12-01 2007-11-15 Process for producing theaflavins
EP07822618A EP2088870A2 (de) 2006-12-01 2007-11-15 Verfahren zur herstellung von theaflavinen

Publications (1)

Publication Number Publication Date
EP2088870A2 true EP2088870A2 (de) 2009-08-19

Family

ID=38057404

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07822618A Withdrawn EP2088870A2 (de) 2006-12-01 2007-11-15 Verfahren zur herstellung von theaflavinen

Country Status (8)

Country Link
US (1) US20080131558A1 (de)
EP (1) EP2088870A2 (de)
JP (1) JP2010510787A (de)
CN (2) CN101541184A (de)
AP (1) AP2009004829A0 (de)
AR (1) AR064063A1 (de)
EA (1) EA200970525A1 (de)
WO (1) WO2008065007A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2096937T3 (pl) * 2006-12-01 2011-06-30 Unilever Nv Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny
ES2391061T3 (es) 2007-11-05 2012-11-21 Unilever N.V. Procedimiento de fabricación de productos de té
EP2222181B1 (de) 2007-11-05 2011-10-12 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Verfahren zur herstellung von teeprodukten
CN102164500B (zh) * 2008-10-02 2014-08-20 荷兰联合利华有限公司 生产茶产品的方法
JP5366739B2 (ja) * 2009-09-25 2013-12-11 花王株式会社 容器詰酸性紅茶飲料
US20110082198A1 (en) * 2009-10-07 2011-04-07 Jiangsu Dehe Bio-Tech Co., Ltd. Theaflavin compositions, production, and methods to control physiological disorders in mammals
US8282970B2 (en) * 2009-10-07 2012-10-09 Jiahgsu Dehe Bio-Tech Co., Ltd Theaflavin compositions, related processes and methods of use
US9078455B2 (en) 2010-03-25 2015-07-14 Conopco, Inc. Process for manufacturing tea products
WO2012069323A1 (en) * 2010-11-24 2012-05-31 Unilever Nv A tea product
CN102228100B (zh) * 2011-08-04 2012-09-12 湖南农业大学 一种高茶黄素红茶制作的方法
CN102640824B (zh) * 2012-03-05 2014-04-30 中国农业科学院茶叶研究所 一种高茶黄素红茶饮料的加工方法
CN102907524A (zh) * 2012-10-31 2013-02-06 深圳市深宝华城科技有限公司 一种具有高含量茶黄素的速溶红茶粉的制备方法
CN103535461A (zh) * 2013-10-11 2014-01-29 集美大学 茶叶的酶法二次加工方法
WO2015082191A1 (en) * 2013-12-06 2015-06-11 Unilever N.V. A process for producing a tea product
CN104286240B (zh) * 2014-10-21 2017-07-21 浙江景宁慧明红实业发展有限公司 同时制备高茶黄素红碎茶和高茶黄素速溶红茶粉的方法
CN104886291A (zh) * 2015-05-15 2015-09-09 安徽大学 一种复合酶制剂及其提升发酵茶品质的方法
CN108294309A (zh) * 2017-01-13 2018-07-20 上海科宝生物技术有限公司 红茶提取物及其制备方法
CN109122935A (zh) * 2018-09-04 2019-01-04 岳西县碧涛农林有限公司 一种高香高茶黄素夏季红茶的加工方法
WO2021099352A1 (en) * 2019-11-21 2021-05-27 Unilever Ip Holdings B.V. A black leaf tea product
CN117625591B (zh) * 2024-01-24 2024-04-26 四川省农业科学院茶叶研究所 一种黑茶用生物复合酶及其制茶工艺

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH429407A (fr) * 1963-11-27 1967-01-31 Nestle Sa Procédé de fabrication d'extraits de thé
GB1204585A (en) * 1968-01-23 1970-09-09 Tenco Brooke Bond Ltd Improvements in or relating to the fermentation of tea
US3812266A (en) * 1972-01-31 1974-05-21 Lipton T Inc Green tea conversion using tannase and natural tea enzymes
DE69611770T2 (de) * 1995-09-04 2001-05-31 Unilever N.V., Rotterdam Verfahren zur Farbvertiefung in Nahrungsmitteln auf Teebasis
CA2252765A1 (en) * 1996-04-25 1997-11-06 Mark Richard Birch Tea processing with zeolites
WO1998023164A1 (en) * 1996-11-29 1998-06-04 Unilever Plc Black leaf tea
EP0891973B1 (de) * 1997-07-15 2001-10-17 Unilever Plc Verbesserungen bezüglich auf Theaflavin Erzeugung
ATE207068T1 (de) * 1997-07-15 2001-11-15 Unilever Nv Verbesserungen bezüglich auf theaflavin erzeugung
ATE233054T1 (de) * 1998-08-17 2003-03-15 Unilever Nv Behandlung von tee mit kohlendioxid
GB0010315D0 (en) * 2000-04-27 2000-06-14 Unilever Plc Black tea manufacture
US6761918B2 (en) * 2002-07-18 2004-07-13 Tata Tea Ltd. Method of processing green tea leaves to produce black tea that can be brewed in cold water
US7829132B2 (en) * 2004-11-03 2010-11-09 Unilever Bestfoods, North America Division Of Conopco, Inc. Consumable tea composition with antioxidants
PL2096937T3 (pl) * 2006-12-01 2011-06-30 Unilever Nv Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008065007A2 *

Also Published As

Publication number Publication date
CN101553125A (zh) 2009-10-07
CN101541184A (zh) 2009-09-23
US20080131558A1 (en) 2008-06-05
WO2008065007A2 (en) 2008-06-05
WO2008065007A3 (en) 2008-09-18
AP2009004829A0 (en) 2009-04-30
JP2010510787A (ja) 2010-04-08
AR064063A1 (es) 2009-03-11
EA200970525A1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
US20080131558A1 (en) Process for producing theaflavins
US6113965A (en) Producing theaflavin
US6482450B1 (en) Cold water infusing leaf tea
EP2096937B1 (de) Verfahren zur herstellung von mit theaflavin angereicherten teeprodukten
AU2008324227B2 (en) Process for manufacturing tea products
EP2334193B1 (de) Verfahren zur herstellung von teeprodukten
US20100086645A1 (en) Process for manufacturing tea products
EP2192844B1 (de) Verfahren zum extrahieren von theaflavinen aus tee
WO2001070038A2 (en) Cold water soluble tea
EP0891973B1 (de) Verbesserungen bezüglich auf Theaflavin Erzeugung
TW201000019A (en) Manufacturing method for theaflavins, using raw tea leaves
CN101675043A (zh) 茶黄素的提取
EP2549880B1 (de) Verfahren zur Herstellung von Teeprodukten
CN119655340A (zh) 一种富含茶黄素的果茶饮料及其制备方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090325

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120206

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120619